SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (8700)5/29/1998 7:34:00 PM
From: Zebra 365  Read Replies (2) of 23519
 
<<<Honestly folks I don't understand why the price of Vivus stock remains so low. Looking at other biotech companies, I know of many one drug companies who don't even have an approved product and are losing as much as over $2.00/share 12 months trailing and yet the share price is significantly higher than that of Vivus.>>>

VLAD, in case you didn't notice, and much of the market didn't, ZONA and SGP got approval to market Vasomax (under the name Z-Max) in Mexico. Many see this as insignificant. But I practice in Dallas and have many patients who drive to Mexico for a years' supply of cheap prescription drugs, and many others (hopefully not my patients) who go to get Valium or Rohypnol (the "date-rape" drug, another benzodiazapine not sold in the US). So I will soon be seeing patients taking Z-Max, and I don't even have a package insert. With NAFTA there is almost no barrier to the flow of prescription drugs from Mexico to the US, and there are many big pharmacerias just across the border that cater to the "Nortamericanos" trade.

I bet they even package the drug for sale in Mexico with bilingual or even all English instructions.

So there were two "new" competitors identified today, I would have been surprised if VVUS didn't drop. But these will all fight for the oral market.

Be patient and accumulate under 10.

Zebra
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News